Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.448NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Q.1 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.46 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.99 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.243NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
R.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.216NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.471NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.420NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
L.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.518NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.551NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.207NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.604NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.111NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.619NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.23.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.316NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.436NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.558NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.368NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.404NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.306NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.328NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.533NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.213NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.341NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.89NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.315NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.204NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.170NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.232NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.84NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.76NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.301NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.269NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used